share_log

富途早报 | 美股狂欢夜!标普500创近两年最佳单日表现;否认衰退论调!美联储官员:美国经济增长和需求仍强劲

Futu Morning Post | Crazy night in the US stock market! S&P 500 achieves its best single-day performance in nearly two years; Denying recession claims! Fed officials: US economic growth and demand remain strong.

Futu News ·  08:07

Hot news

  • The number of initial jobless claims in the United States last week, the largest drop in a year, was 0.233 million, lower than expected and the previous value.

On Thursday, August 8th, the US Department of Labor published data showing that 233,000 people filed for initial jobless claims in the week of August 3, lower than the expected 240,000 and lower than the previous 249,000. For most of this year, the number of people applying for unemployment benefits has been on the rise. The number of initial jobless claims in the United States has dropped significantly, marking the largest decline in a year and indicating a rebound in the job market.

  • Fed's Schmid: Rate cuts are appropriate if inflation persists at a low level

Fed's Schmid said that rate cuts are appropriate if inflation persists at a low level, even though the July employment report was weak; economic growth and demand remain strong; the current Fed policy stance is not so restrictive; encouraged by recent inflation data, more confident that inflation is on the path to target achievement; the Fed's policy path will be determined by data and the strength of the economy.

  • Fed's Bullard: Uncertainty remains as to whether the job market will continue to be maintained or deteriorate

Fed's Bullard said that the Fed is paying attention to the market, but the market is not driving FOMC's monetary policy; it is uncertain whether the job market will continue to be maintained or deteriorate; what needs to be seen is not only non-farm employment data, not only one month's data; now we are returning to a more normal state; need to pay attention to the real economy if the tightness lasts too long.

  • Jpmorgan: If there is no urgency for the Federal Reserve to relax monetary policy, US stocks still face risks.

According to the latest analysis by JPMorgan analyst Lakos-Bujas, the recent drop in the US stock market has burst some of the bubbles in the market. However, if the growth of the US economy continues to slow down, and the Federal Reserve has not shown any urgency to relax the monetary policy, the related positions and valuations of US stocks still face risks.

  • Trump and Harris have agreed to hold a debate on September 10th.

US presidential candidates Trump and Harris have agreed to a debate hosted by ABC on September 10th.

  • The market seeks higher yields, and the auction of 30-year US government bonds is once again weak.

On Thursday, eastern US time, the US Treasury auctioned $25 billion of 30-year Treasuries. The result continued the trend of yesterday's weak auction of 10-year US Treasuries. The bid rate for this 30-year US Treasury auction was 4.314%, the lowest yield since January of this year, when it was 4.229%, and the bid rate for July 11 was 4.405%. The pre-issuance rate for this auction was 4.283%, with a tail spread of 3.1 basis points, the largest tail spread since November of last year.

Gamestop's surge has dramatically narrowed, with the trading platform considering unplugging the internet of US retail investors.

  • US stocks opened high and closed high, with the NASDAQ rising nearly 3% to lead the three major indices.

On Thursday, US stocks opened high and closed high, with the three major indices rising sharply. At the close, the Dow Jones Industrial Average rose 1.76%; the S&P 500 Index rose 2.30%, marking the best single-day performance since November 2022; and the Nasdaq Composite Index rose 2.87%, crossing more than 3% at one point.

Large technology stocks rose collectively, with NVIDIA up 6.13%, Meta up 4.24%, Tesla up 3.69%, Google C up 1.92%, Amazon up 1.86%, Apple up 1.66%, and Microsoft up 1.07%.

The two giants of weight-loss drugs have exploded, with Eli Lilly and Co soaring 9.48% and Novo-Nordisk A/S up 7.50%.

Popular China concept stocks are up across the board, with the Nasdaq Golden Dragon China Index up 2.80%, Baidu up 5.52%, Tal Education up 4.12%, Nio Inc up 4.09%, PDD Holdings up 3.66%, Xpeng up 3.51%, Alibaba up 3.19%, and Li Auto Inc up 2.60%.

  • Apple plans to launch its smallest Mac desktop computer to date, equipped with the M4 chip.

$Apple (AAPL.US)$The company plans to launch a new version of the Mac mini, which will be the company's smallest desktop computer to date. According to anonymous insiders, the new device will be much smaller than the previous generation and roughly the size of an Apple TV box. The updated mini is one of several new Macs expected to be released over the next few months. The company is preparing to equip iMacs and MacBook Pros with the M4 chip, which could be released as early as this year.

  • Apple has changed the terms of the App Store agreement, allowing European developers to promote their products outside the ecosystem.

On Thursday, August 8th, Eastern Time, Apple announced that it will make major updates to its App Store policy to comply with the EU Digital Markets Act. The new policy will take effect this autumn and will allow app developers in the EU region to promote and sell products within their apps, no longer limited to the Apple App Store.

  • Up nearly 10%, Lilly's performance greatly exceeded expectations, with a market capitalization approaching $800 billion.

$Eli Lilly and Co (LLY.US)$ Up nearly 10%, the financial report shows that second-quarter revenue was $11.3 billion (an increase of 36% year-on-year), exceeding market expectations of $9.92 billion; net income was $2.97 billion (an increase of 68% year-on-year), adjusted earnings per share were $3.92, far exceeding the expected $2.60. Due to the strong performance of weight-loss drugs, the company raised its revenue guidance for the fiscal year for a second time to $45.4-46.6 billion; the adjusted earnings per share for the full year will be $16.10-16.60, compared to the previous guidance of $13.50-14.

  • Soundhound AI's revenue growth in Q2 was 54%, but losses expanded by 30% after rising more than 10% after hours.

Voice AI company$SoundHound AI (SOUN.US)$After rising more than 10% after hours, the financial report shows that the second-quarter performance was mixed, with revenue growth slowing but better than expected, and the company raised its full-year revenue guidance. However, the severity of the second-quarter loss expansion exceeded market expectations. Second-quarter revenue increased by 54% year-on-year, still stronger than expected, and EBITDA losses expanded by 30%, ten times larger than in the first quarter.

  • After-hours up 5%, Paramount Global's adjusted EPS for Q2 continued operations exceeded expectations.

$Paramount Global-B (PARA.US)$ After-hours up 5%, Paramount Global's Q2 revenue was $6.81 billion, lower than analysts' expectations of $7.24 billion. Q2 adjusted EPS for continuing operations was $0.54, much higher than analysts' expectation of $0.13. Q2 Paramount+ streaming subscription users were 68 million, lower than analysts' expectation of 71.22 million. Q2 advertising revenue was $2.25 billion, which exceeded analysts' expectations of $2.24 billion. Q2 revenue includes $5.98 billion in network charges.

  • The global regulatory anti-monopoly storm continues, Amazon's $4 billion investment in Anthropic is under review by UK regulators.

$Amazon (AMZN.US)$ The UK regulatory agency has launched a formal investigation into Amazon's $4 billion investment in AI company Anthropic. The Competition and Markets Authority (CMA) announced on Thursday that it has launched a "Phase One" investigation into the multi-billion dollar investment by the e-commerce giant into the US artificial intelligence firm. This is to assess whether the investment could have an adverse impact on competition in the UK market.

  • Energy drink giant Monster Beverage fell more than 10% as revenue, profits, and sales fell short of expectations.

$Monster Beverage (MNST.US)$Monster Beverage fell more than 10% as Q2 revenue came in at $1.9 billion, lower than the expected $2.02 billion, with YoY revenue growth of 2.5%, the slowest since Q2 2020. Total sales for Q2 were 0.21219 billion cases, falling to the lowest level since the early days of the COVID-19 pandemic and lower than the expected 0.21542 billion cases.

  • Two AI drug companies announced a merger to create one of the largest AI Bio mergers.

August 8th,$Recursion Pharmaceuticals (RXRX.US)$And.$Exscientia (EXAI.US)$Announced on August 8th, the two companies have reached a final agreement to merge Recursion and Exscientia. The former is a leading clinical-stage biotechnology company that is able to industrialize biological decoding to achieve drug discovery, while the latter is a technology-driven clinical-stage drug design and development company focused on creating more effective drugs for patients. After the merger, it will become one of the largest AI Bio mergers.

If you want to play this game, you must believe in yourself and your judgment.

BeiShui crazily bought China Mobile for nearly HKD 1.8 billion and sold Tencent for about HKD 200 million. On Monday (June 3rd), Southbound funds net purchased HKD 3.4 billion of Hong Kong stocks.

  • Beishui added over HKD 0.7 billion to Tencent and sold nearly HKD 7 billion in Tracker Fund of Hong Kong shares.

On Thursday, southbound funds sold HKD 6.086 billion of Hong Kong stocks.

$TENCENT.HK$,$CHINA MOBILE.HK$,$CNOOC.HK$Buys were respectively HKD 0.733 billion, HKD 0.519 billion and HKD 88.08 million;

$TRACKER FUND OF HONG KONG.HK$,$Hang Seng H-Share Index ETF.HK$,$CSOP Hang Seng TECH Index ETF.HK$Sells were respectively HKD 6.837 billion, HKD 1.486 billion, and HKD 1.012 billion.

The company's overall sales volume in 2023 was 18,000 kiloliters, with a year-on-year increase of 28.10%, indicating significant growth. In terms of product structure, the operating income of products worth 10-30 billion yuan were 401/1288/60 million yuan respectively.

Keywords: China CPI, PPI, M2 money supply annual rate; Genscript Bio, Nikola earnings.

On Friday, various important economic data, such as China's CPI, PPI, M2 money supply growth rate, and new RMB loans, will be released one after another.

Regarding financial reports,$GENSCRIPT BIO (01548.HK)$,$Nikola (NKLA.US)$The financial report is coming.

000.png

Futubull Morning News:

"Because I consider myself a business operator, I become a better investor. Because I consider myself an investor, I become a better business operator."

- Buffett

Editor/ping

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment